In an earnings call earlier this week Compass Pathways confirmed that its heavily anticipated Phase 2b data is still expected to be shared by the end of the year. Some attendees on the call asked for further information on an Opinion issued by the UK IP Office that found some of the claims in one of the company’s UK patents to be lacking an “inventive step.” CEO George Goldsmith emphasised the non…
